Sulfamethoxazole and Trimethoprim Injection
»Sulfamethoxazole and Trimethoprim Injection is a sterile solution of Sulfamethoxazole and Trimethoprim in Water for Injection,which,when diluted with Dextrose Injection,is suitable for intravenous infusion.It contains not less than 90.0percent and not more than 110.0percent of the labeled amounts of sulfamethoxazole (C10H11N3O3S)and trimethoprim (C14H18N4O3).
Packaging and storage— Preserve in single-dose,light-resistant containers,preferably of Type Iglass.It may be packaged in 50-mLmultiple-dose containers.
Labeling— Label it to indicate that it is to be diluted with 5%Dextrose Injection prior to administration.
Identification— In tests Aand Bunder Related compounds,the respective Test preparationsexhibit principal spots whose RFvalues correspond to those spots produced by the Standard preparationsof USP Trimethoprim RS(RFabout 0.5)and USP Sulfamethoxazole RS(RFabout 0.7).
Pyrogen— It meets the requirements of the Pyrogen Test á151ñ,the test dose being 0.5mLper kg.
pHá791ñ: between 9.5and 10.5.
Particulate matter á788ñ: meets the requirements for small-volume injections.
Related compounds—
TEST A(FOR TRIMETHOPRIM DEGRADATION PRODUCT)—
Hydrochloric acid solution— Dilute 2mLof 3Nhydrochloric acid with water to 100mL.
Test preparation— Transfer an accurately measured volume of Injection,equivalent to about 48mg of trimethoprim and 240mg of sulfamethoxazole,to a glass-stoppered,50-mLcentrifuge tube.Add 15mLof Hydrochloric acid solution,and mix.Add 15mLof chloroform,shake for 30seconds,and centrifuge at high speed for 3minutes.Transfer the supernatant layer to a 125-mLseparator.Extract the chloroform layer in the centrifuge tube with 15mLof Hydrochloric acid solution,centrifuge at high speed,and add the extract to the separator.Add 2mLof sodium hydroxide solution (1in 10)to the solution in the separator,and extract with three 20-mLportions of chloroform,collecting the organic layer in a 125-mLconical flask.Evaporate the chloroform under a stream of nitrogen to dryness.Dissolve the residue in 1mLof a mixture of chloroform and methanol (1:1).
Standard preparation A— Using an accurately weighed quantity of USP Trimethoprim RS,prepare a solution in chloroform and methanol (1:1)having a known concentration of 48mg per mL.
Standard preparation B— Dilute an accurately measured volume of Standard preparation Awith a mixture of chloroform and methanol (1:1)to obtain a solution having a known concentration of 240µg per mL.
Procedure— Apply 10µLeach of the Test preparation,Standard preparation A,and Standard preparation Bto separate points on a thin-layer chromatographic plate (see Chromatography á621ñ)coated with a 0.25-mm layer of chromatographic silica gel.Develop the chromatogram in a solvent system consisting of a mixture of chloroform,methanol,and ammonium hydroxide (97:7.5:1)until the solvent front has moved at least 12cm.Remove the plate from the developing chamber,and air-dry.Locate the bands by viewing under short-wavelength UVlight and by spraying with a freshly prepared mixture of ferric chloride solution (1in 10)and potassium ferricyanide solution (1in 20)(1:1).Trimethoprim produces a spot at about RF0.5,and the trimethoprim degradation product produces a spot at about RF0.6to 0.7.Any spot from the Test preparationat about RF0.6to 0.7is not greater in size and intensity than the spot produced by Standard preparation Bat about RF0.5,corresponding to not more than 0.5%.[NOTE—There may be spots due to concentrate excipients at about RF0.1.]
TEST B(FOR SULFANILAMIDE AND SULFANILIC ACID)—
Alcohol–methanol mixture— Mix dehydrated alcohol and methanol (95:5).
Ammonium hydroxide solution— Dilute 1mLof ammonium hydroxide with Alcohol-methanol mixtureto 100mL.
Modified Ehrlich's reagent— Dissolve 100mg of p-dimethylaminobenzaldehyde in 1mLof hydrochloric acid,dilute with alcohol to 100mL,and mix.
Test preparation— Transfer an accurately measured volume of Injection,equivalent to about 32mg of trimethoprim and 160mg of sulfamethoxazole,to a 25-mLgraduated cylinder,dilute with Ammonium hydroxide solutionto 16mL,and mix.
Standard preparation A— Transfer about 50mg of USP Sulfamethoxazole RS,accurately weighed,to a 5-mLvolumetric flask,dissolve in and dilute with Ammonium hydroxide solutionto volume,and mix.
Standard preparation B— Transfer about 25mg of USP Sulfanilamide RS,accurately weighed,to a 250-mLvolumetric flask,dissolve in and dilute with Ammonium hydroxide solutionto volume,and mix.Pipet 5mLof this solution into a 10-mLvolumetric flask,dilute with Ammonium hydroxide solutionto volume,and mix.
Standard preparation C— Transfer about 25mg of USP Sulfanilic Acid RS,accurately weighed,to a 250-mLvolumetric flask,dissolve in and dilute with Ammonium hydroxide solution,and mix.Pipet 3mLof this solution into a 10-mLvolumetric flask,dilute with Ammonium hydroxide solutionto volume,and mix.
Procedure— Apply 10µLeach of the Test preparationand Standard preparations A,B,and Cto separate points on a thin-layer chromatographic plate (see Chromatography á621ñ)coated with a 0.25-mm layer of chromatographic silica gel.Develop the chromatogram in a solvent system consisting of a mixture of Alcohol-methanol mixture,heptane,chloroform and glacial acetic acid (30:30:30:10)until the solvent front has moved not less than 12cm.Remove the plate from the developing chamber,air-dry,spray with Modified Ehrlich's reagent,and allow the plate to stand for 15minutes:sulfamethoxazole produces a spot at about RF0.7.Any spots from the Test preparationat about RF0.5or 0.1are not greater in size or intensity than spots produced by Standard preparations Band C,respectively,corresponding to not more than 0.5%of sulfanilamide and 0.3%of sulfanilic acid.
Other requirements— It meets the requirements under Injections á1ñ.
Assay—
Mobile phase,Standard preparation,and Chromatographic system— Proceed as directed in the Assayunder Sulfamethoxazole and Trimethoprim Oral Suspension.
Assay preparation— Transfer an accurately measured volume of Injection,equivalent to about 80mg of sulfamethoxazole,to a 50-mLvolumetric flask.Add methanol to volume,and mix.Transfer 5.0mLof this solution to a 50-mLvolumetric flask,dilute with Mobile phaseto volume,mix,and filter.
Procedure— Separately inject equal volumes (about 20µL)of the Standard preparationand the Assay preparationinto the chromatograph,record the chromatograms,and measure the responses for the major peaks.Calculate the quantities,in mg,of trimethoprim (C14H18N4O3)and sulfamethoxazole (C10H11N3O3S)in each mLof the Injection taken by the formula:
(500C/V)(rU/rS),
in which Cis the concentration,in mg per mL,of the appropriate USP Reference Standard in the Standard preparation;and rUand rSare the responses of the corresponding analyte obtained from the Assay preparationand the Standard preparation,respectively.
Auxiliary Information— Staff Liaison:Behnam Davani,Ph.D.,MBA,Senior Scientist
Expert Committee:(PA7)Pharmaceutical Analysis 7
USP28–NF23Page 1829
Pharmacopeial Forum:Volume No.29(3)Page 670
Phone Number:1-301-816-8394